Ocugen (OCGN) Exchange Rate Effect (2018 - 2026)
Ocugen (OCGN) reported Exchange Rate Effect of $102000.0 for Q1 2026, up 1375.0% on a YoY basis from $6915.3 in Q1 2025, and up 3300.0% quarter-over-quarter from $3000.0 in Q4 2025.
Ocugen (OCGN) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Ocugen has reported Exchange Rate Effect for 7 years, with the latest figure at $102000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 1375.0% year-over-year to $102000.0; the trailing twelve-month figure through Mar 2026 stood at $123000.0 (up 720.0% YoY), and the FY2025 full-year result was $13000.0, down 53.57% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $102000.0, up from $3000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $102000.0 in Q1 2026, with the low at -$28000.0 in Q2 2025.
- Historically, Exchange Rate Effect has averaged $10187.5 across 5 years, with a median of $3000.0 in 2024.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect slumped 1033.33% — and 2026, when it surged 1375.0%.
- Ocugen's Exchange Rate Effect stood at -$5000.0 in 2022, then sank by 40.0% to -$7000.0 in 2023, then soared by 457.14% to $25000.0 in 2024, then tumbled by 88.0% to $3000.0 in 2025, then soared by 3300.0% to $102000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $102000.0 (Q1 2026), $3000.0 (Q4 2025), and $46000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 102,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102,000.00 |
| Mar 31, 2026 | 102,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |